Girardot et al. observed miR-28 overexpression in the platelets of patients with BCR-ABL negative myeloproliferative neoplasms, and they identified MPL, an important regulator for megakaryocyte differentiation, to be the main target of miR-28 [33]. The gene discussed is MPL; the disease is myeloproliferative disorder.